Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
Francis Grand, Claire Hidalgo-Curtis, Thomas Ernst, et al.
Blood (2009) Vol. 113, Iss. 24, pp. 6182-6192
Open Access | Times Cited: 366

Showing 26-50 of 366 citing articles:

Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases
Bhopal Mohapatra, Gulzar Ahmad, Scott Nadeau, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2012) Vol. 1833, Iss. 1, pp. 122-139
Open Access | Times Cited: 214
From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms
Mario Cazzola, Róbert Královics
Blood (2014) Vol. 123, Iss. 24, pp. 3714-3719
Open Access | Times Cited: 195
Heterozygous Germline Mutations in the CBL Tumor-Suppressor Gene Cause a Noonan Syndrome-like Phenotype
Simone Martinelli, Alessandro De Luca, Emilia Stellacci, et al.
The American Journal of Human Genetics (2010) Vol. 87, Iss. 2, pp. 250-257
Open Access | Times Cited: 249
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
Olivier Kosmider, Véronique Gelsi‐Boyer, Marion Ciudad, et al.
Haematologica (2009) Vol. 94, Iss. 12, pp. 1676-1681
Open Access | Times Cited: 239
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
Christine L. O’Keefe, Michael A. McDevitt, Jaroslaw P. Maciejewski
Blood (2010) Vol. 115, Iss. 14, pp. 2731-2739
Open Access | Times Cited: 219
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
Thorsten Braun, Raphaël Itzykson, Aline Renneville, et al.
Blood (2011) Vol. 118, Iss. 14, pp. 3824-3831
Open Access | Times Cited: 197
Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies
Hideki Makishima, Anna Jankowska, Ramón V. Tiu, et al.
Leukemia (2010) Vol. 24, Iss. 10, pp. 1799-1804
Closed Access | Times Cited: 179
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
Manja Meggendorfer, Ulrike Bacher, Tamara Alpermann, et al.
Leukemia (2013) Vol. 27, Iss. 9, pp. 1852-1860
Closed Access | Times Cited: 177
Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl
Hao Dou, Lori Buetow, Andreas Hock, et al.
Nature Structural & Molecular Biology (2012) Vol. 19, Iss. 2, pp. 184-192
Open Access | Times Cited: 177
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Joannah Score, Claire Hidalgo-Curtis, Amy V. Jones, et al.
Blood (2011) Vol. 119, Iss. 5, pp. 1208-1213
Open Access | Times Cited: 166
DNMT3A mutations in myeloproliferative neoplasms
Frank Stegelmann, Lars Bullinger, Richard F. Schlenk, et al.
Leukemia (2011) Vol. 25, Iss. 7, pp. 1217-1219
Closed Access | Times Cited: 166
Myeloproliferative neoplasm stem cells
Adam J. Mead, Ann Mullally
Blood (2017) Vol. 129, Iss. 12, pp. 1607-1616
Open Access | Times Cited: 158
Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia
Mignon L. Loh
British Journal of Haematology (2011) Vol. 152, Iss. 6, pp. 677-687
Open Access | Times Cited: 155
The importance of regulatory ubiquitination in cancer and metastasis
Leandro H. Gallo, Juyeon Ko, Daniel J. Donoghue
Cell Cycle (2017) Vol. 16, Iss. 7, pp. 634-648
Open Access | Times Cited: 152
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms
Mandy Brecqueville, Jérôme Rey, François Bertucci, et al.
Genes Chromosomes and Cancer (2012) Vol. 51, Iss. 8, pp. 743-755
Closed Access | Times Cited: 149
DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms
Omar Abdel‐Wahab, Animesh Pardanani, Raajit K. Rampal, et al.
Leukemia (2011) Vol. 25, Iss. 7, pp. 1219-1220
Open Access | Times Cited: 147
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
Hideki Makishima, Anna Jankowska, Michael A. McDevitt, et al.
Blood (2011) Vol. 117, Iss. 21, pp. e198-e206
Open Access | Times Cited: 144
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
Roland Jäger, Heinz Gisslinger, Francesco Passamonti, et al.
Leukemia (2010) Vol. 24, Iss. 7, pp. 1290-1298
Closed Access | Times Cited: 142
Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia
B. Perez, Françoise Méchinaud, Claire Galambrun, et al.
Journal of Medical Genetics (2010) Vol. 47, Iss. 10, pp. 686-691
Open Access | Times Cited: 140
Myeloid malignancies: mutations, models and management
Anne Murati, Mandy Brecqueville, Raynier Devillier, et al.
BMC Cancer (2012) Vol. 12, Iss. 1
Open Access | Times Cited: 138
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
Animesh Pardanani, Alessandro M. Vannucchi, Francesco Passamonti, et al.
Leukemia (2010) Vol. 25, Iss. 2, pp. 218-225
Closed Access | Times Cited: 128
Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of Age
Stephen C. Kales, Philip Ryan, Marion M. Nau, et al.
Cancer Research (2010) Vol. 70, Iss. 12, pp. 4789-4794
Open Access | Times Cited: 127
How I treat myelofibrosis
Ayalew Tefferi
Blood (2011) Vol. 117, Iss. 13, pp. 3494-3504
Closed Access | Times Cited: 125
Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms
Nicholas C.P. Cross
Hematology (2011) Vol. 2011, Iss. 1, pp. 208-214
Open Access | Times Cited: 121
Pathogenesis of myeloproliferative neoplasms
Radek C. Skoda, Adrian Duek, Jean Grisouard
Experimental Hematology (2015) Vol. 43, Iss. 8, pp. 599-608
Open Access | Times Cited: 106

Scroll to top